FS222 Mab2, a Bispecific Conditional Agonist Antibody Targeting CD137 and PD-L1, Induces Potent Lymphocyte Activation and Has a Favorable Safety Profile
Immunology(2019)
Key words
Bispecific Antibodies
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined